1. Home
  2. MNOV vs KNDI Comparison

MNOV vs KNDI Comparison

Compare MNOV & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • KNDI
  • Stock Information
  • Founded
  • MNOV 2000
  • KNDI 2002
  • Country
  • MNOV United States
  • KNDI China
  • Employees
  • MNOV N/A
  • KNDI N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • KNDI Auto Manufacturing
  • Sector
  • MNOV Health Care
  • KNDI Consumer Discretionary
  • Exchange
  • MNOV Nasdaq
  • KNDI Nasdaq
  • Market Cap
  • MNOV 89.8M
  • KNDI 91.2M
  • IPO Year
  • MNOV 2005
  • KNDI N/A
  • Fundamental
  • Price
  • MNOV $1.90
  • KNDI $1.09
  • Analyst Decision
  • MNOV Strong Buy
  • KNDI
  • Analyst Count
  • MNOV 1
  • KNDI 0
  • Target Price
  • MNOV $9.00
  • KNDI N/A
  • AVG Volume (30 Days)
  • MNOV 20.7K
  • KNDI 126.4K
  • Earning Date
  • MNOV 02-13-2025
  • KNDI 03-13-2025
  • Dividend Yield
  • MNOV N/A
  • KNDI N/A
  • EPS Growth
  • MNOV N/A
  • KNDI N/A
  • EPS
  • MNOV N/A
  • KNDI N/A
  • Revenue
  • MNOV N/A
  • KNDI $118,127,232.00
  • Revenue This Year
  • MNOV N/A
  • KNDI N/A
  • Revenue Next Year
  • MNOV N/A
  • KNDI N/A
  • P/E Ratio
  • MNOV N/A
  • KNDI N/A
  • Revenue Growth
  • MNOV N/A
  • KNDI N/A
  • 52 Week Low
  • MNOV $1.12
  • KNDI $0.89
  • 52 Week High
  • MNOV $2.55
  • KNDI $2.98
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 45.15
  • KNDI 48.75
  • Support Level
  • MNOV $1.87
  • KNDI $1.03
  • Resistance Level
  • MNOV $2.06
  • KNDI $1.20
  • Average True Range (ATR)
  • MNOV 0.08
  • KNDI 0.07
  • MACD
  • MNOV 0.00
  • KNDI -0.01
  • Stochastic Oscillator
  • MNOV 47.48
  • KNDI 21.15

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.

Share on Social Networks: